JP2023548509A5 - - Google Patents
Info
- Publication number
- JP2023548509A5 JP2023548509A5 JP2023526662A JP2023526662A JP2023548509A5 JP 2023548509 A5 JP2023548509 A5 JP 2023548509A5 JP 2023526662 A JP2023526662 A JP 2023526662A JP 2023526662 A JP2023526662 A JP 2023526662A JP 2023548509 A5 JP2023548509 A5 JP 2023548509A5
- Authority
- JP
- Japan
- Prior art keywords
- car
- cell therapy
- individual
- expression level
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063109611P | 2020-11-04 | 2020-11-04 | |
| US63/109,611 | 2020-11-04 | ||
| PCT/US2021/058102 WO2022098903A1 (en) | 2020-11-04 | 2021-11-04 | Methods for diagnosing or treating health conditions or optimizing therapeutic efficacy of car-t cells therapies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023548509A JP2023548509A (ja) | 2023-11-17 |
| JP2023548509A5 true JP2023548509A5 (https=) | 2024-11-12 |
Family
ID=81458287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023526662A Pending JP2023548509A (ja) | 2020-11-04 | 2021-11-04 | 健康状態を診断又は治療するための、もしくはｃａｒ－ｔ細胞療法の治療有効性を最適化するための方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250281532A1 (https=) |
| EP (1) | EP4240771A4 (https=) |
| JP (1) | JP2023548509A (https=) |
| KR (1) | KR20230091177A (https=) |
| CN (1) | CN116745320A (https=) |
| AU (1) | AU2021374937A1 (https=) |
| CA (1) | CA3196359A1 (https=) |
| GB (1) | GB2616162A (https=) |
| IL (1) | IL302450A (https=) |
| MX (1) | MX2023004929A (https=) |
| WO (1) | WO2022098903A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116516007B (zh) * | 2023-04-18 | 2024-01-19 | 华中科技大学同济医学院附属协和医院 | Cd19表达的检测方法 |
| WO2024227096A1 (en) * | 2023-04-28 | 2024-10-31 | Sana Biotechnology, Inc. | Anti-cd19 car t cells for treating b-cell malignancies and autoimmune diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103175966B (zh) * | 2012-10-31 | 2015-09-09 | 北京大学人民医院 | 急性b淋巴细胞白血病启动细胞表型分类试剂盒及其应用 |
| KR20170068504A (ko) * | 2014-10-08 | 2017-06-19 | 노파르티스 아게 | 키메라 항원 수용체 요법에 대한 치료 반응성을 예측하는 바이오마커 및 그의 용도 |
| WO2018081830A1 (en) * | 2016-10-31 | 2018-05-03 | Oregon Health & Science University | Combinations of agents to treat hematological malignancies |
| EP3788369A1 (en) * | 2018-05-01 | 2021-03-10 | Novartis Ag | Biomarkers for evaluating car-t cells to predict clinical outcome |
-
2021
- 2021-11-04 US US18/251,697 patent/US20250281532A1/en active Pending
- 2021-11-04 WO PCT/US2021/058102 patent/WO2022098903A1/en not_active Ceased
- 2021-11-04 JP JP2023526662A patent/JP2023548509A/ja active Pending
- 2021-11-04 GB GB2308212.6A patent/GB2616162A/en not_active Withdrawn
- 2021-11-04 EP EP21890083.5A patent/EP4240771A4/en active Pending
- 2021-11-04 CN CN202180088499.4A patent/CN116745320A/zh active Pending
- 2021-11-04 IL IL302450A patent/IL302450A/en unknown
- 2021-11-04 CA CA3196359A patent/CA3196359A1/en active Pending
- 2021-11-04 MX MX2023004929A patent/MX2023004929A/es unknown
- 2021-11-04 KR KR1020237018339A patent/KR20230091177A/ko active Pending
- 2021-11-04 AU AU2021374937A patent/AU2021374937A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yang et al. | Metastasis predictive signature profiles pre-exist in normal tissues | |
| CN103717755B (zh) | 预测dlbcl患者对于抗-cd20治疗的响应 | |
| JP7665659B2 (ja) | 循環腫瘍核酸分子のマルチモーダル分析 | |
| EP2925885A1 (en) | Molecular diagnostic test for cancer | |
| US20140127690A1 (en) | Mutation Signatures for Predicting the Survivability of Myelodysplastic Syndrome Subjects | |
| CN112639983B (zh) | 微卫星不稳定性检测 | |
| JP7197915B2 (ja) | エンザスタウリンの活性を予測するための方法および組成物 | |
| Iriyama et al. | Using peripheral blood circulating DNAs to detect CpG global methylation status and genetic mutations in patients with myelodysplastic syndrome | |
| US20190203298A1 (en) | Method and kit for the diagnosis of lung cancer | |
| JP2023548509A5 (https=) | ||
| US11015223B2 (en) | Methods for determining response to a hypomethylating agent | |
| CN104080928A (zh) | 用于诊断和/或预后妇科癌症的方法 | |
| GB2616162A (en) | Methods for diagnosing or treating health conditions or optimizing therapeutic efficacy of CAR-T cells therapies | |
| US20110263448A1 (en) | Interferon Response in Clinical Samples (IRIS) | |
| US20180127831A1 (en) | Prognostic markers of acute myeloid leukemia survival | |
| US20220290243A1 (en) | Identification of patients that will respond to chemotherapy | |
| KR102195591B1 (ko) | Glut3의 다형성을 이용한 비소세포폐암의 예후 진단 방법 | |
| TWI579722B (zh) | 藥物不良反應風險評估方法及其裝置 | |
| KR20200025968A (ko) | 폐선암종 환자의 예후 진단 및 치료 전략 결정용 성별 특이적 바이오 마커 | |
| US12195806B2 (en) | P16 positive tumor stratification assays and methods | |
| KR102268059B1 (ko) | 운동 민감도 예측용 조성물, 키트, 및 이를 이용한 방법 | |
| RU2683251C1 (ru) | Способ диагностики светлоклеточного почечно-клеточного рака и способ прогнозирования метастазирования на основе группы генов микроРНК | |
| WO2017106365A1 (en) | Methods for measuring mutation load | |
| US10550432B2 (en) | Method for predicting risk of ankylosing spondylitis using DNA copy number variants | |
| JP2008187909A (ja) | 核酸内の変異認識方法 |